NCT04236934View on ClinicalTrials.gov

Thoracentesis: Symptoms and Prediction of the Need for Therapeutic Thoracentesis

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

April 4, 2022

Conditions
Pleural EffusionDyspneaPatient Reported OutcomesDiaphragm MovementUltrasound
Interventions
OTHER

Assesment of diaphragm shape and diaphragm movement (by M-mode and the AREA-method) by ultrasound before and after thoracentesis

Questionnaire is about symptoms measured by Edmonton Symptom Assessment Score (ESAS) and dyspnea also by modified Borg Scale (MBS)

Trial Locations (2)

4000

Zealand University Hospital, Roskilde, Roskilde

4700

Næstved Sygehus, department of pulmonary medicine, Næstved

All Listed Sponsors
lead

Naestved Hospital

OTHER

NCT04236934 - Thoracentesis: Symptoms and Prediction of the Need for Therapeutic Thoracentesis | Biotech Hunter | Biotech Hunter